Generated by GPT-5-mini| Brain Attack Coalition | |
|---|---|
| Name | Brain Attack Coalition |
| Formation | 1990s |
| Headquarters | United States |
| Leader title | Chair |
| Fields | Stroke care, Neurology, Emergency medicine, Public health |
Brain Attack Coalition The Brain Attack Coalition is a consortium of professional American Heart Association, American Stroke Association, National Institutes of Health, Centers for Disease Control and Prevention, and clinical specialty organizations convened to improve acute stroke care. It developed consensus-based models and recommendations for organized stroke services in collaboration with specialty societies such as the American Academy of Neurology, Society of NeuroInterventional Surgery, American College of Emergency Physicians, and American Association of Neurological Surgeons. The Coalition’s work has informed policy by linking evidence from Randomized controlled trials, guideline development by bodies like the Institute of Medicine, and service implementation across regional health systems including Johns Hopkins Hospital, Mayo Clinic, and Cleveland Clinic.
The Coalition emerged in the 1990s amid growing interest following pivotal trials including the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study and the increasing use of intravenous thrombolysis. Early meetings brought together stakeholders from the American Heart Association, American Stroke Association, National Institutes of Health, Centers for Disease Control and Prevention, American College of Emergency Physicians, American Academy of Neurology, Society of NeuroInterventional Surgery, and regional stroke centers. Consensus statements and white papers published by the Coalition in the early 2000s built on experiences from leading institutions such as Massachusetts General Hospital, Barnes-Jewish Hospital, and Mount Sinai Hospital and paralleled developments in stroke systems of care in jurisdictions like New York City and Los Angeles County.
Membership is composed of representatives from major professional organizations and federal agencies: American Heart Association, American Stroke Association, National Institutes of Health, Centers for Disease Control and Prevention, American Academy of Neurology, Society of NeuroInterventional Surgery, American College of Emergency Physicians, American Association of Neurological Surgeons, and allied specialty groups including American Association of Critical-Care Nurses and American Association of Neurological Surgeons. Organizational structure relies on working groups and task forces that mirror clinical pathways employed at tertiary referral centers such as Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, and academic departments at institutions like Harvard Medical School and University of California, San Francisco. Chairs and co-chairs typically include leaders drawn from academia, federal agencies, and specialty societies such as the Society of Vascular and Interventional Neurology.
The Coalition promulgated standardized definitions for levels of stroke care—commonly known as Primary Stroke Center, Comprehensive Stroke Center, and Acute Stroke-Ready Hospital—reflecting capabilities identified at centers including Emory University Hospital, University of Pennsylvania Health System, and UCLA Health. Core goals include timely reperfusion as demonstrated in trials like the ECASS III and MR CLEAN studies, organized protocols for emergency medical services as modeled in regions such as King County, Washington and Rochester, Minnesota, and quality measurement consistent with reporting systems used by Centers for Medicare & Medicaid Services and registries like Get With The Guidelines–Stroke. Definitions emphasize multidisciplinary teams encompassing neurologists from American Academy of Neurology membership, neurosurgeons affiliated with American Association of Neurological Surgeons, interventionalists from Society of NeuroInterventional Surgery, and emergency physicians from American College of Emergency Physicians.
The Coalition issued recommendations covering door-to-needle time benchmarks, imaging protocols involving Computed tomography, Magnetic resonance imaging, and vascular imaging modalities employed at centers such as Massachusetts General Hospital and Cleveland Clinic, and criteria for patient triage and transfer paralleling regional systems like London Ambulance Service and Sydney Local Health District. Protocols align with guideline documents from the American Heart Association and integrate evidence from thrombectomy trials including EXTEND-IA, ESCAPE, and SWIFT PRIME. Recommendations specify infrastructure (24/7 neurointerventional capability), staffing (neurocritical care teams), and performance metrics tracked in registries like Get With The Guidelines–Stroke and quality programs run by Centers for Medicare & Medicaid Services.
Adoption of Coalition recommendations coincided with increased use of intravenous thrombolysis and mechanical thrombectomy at institutions such as Mayo Clinic, Mount Sinai Hospital, and Johns Hopkins Hospital, and with improved process metrics—reduced door-to-needle times and expanded access to reperfusion therapies. Regional implementation in metropolitan systems like New York City and statewide initiatives in places like Florida and California demonstrated associations with decreased in-hospital mortality and improved functional outcomes in observational analyses. The Coalition’s frameworks influenced accreditation programs (Primary Stroke Center, Comprehensive Stroke Center) administered by agencies and organizations including The Joint Commission and informed reimbursement and performance measurement initiatives linked to Centers for Medicare & Medicaid Services.
Critics have argued that standardized certification models advocated by the Coalition may reinforce centralization favoring large academic centers such as Johns Hopkins Hospital and Mayo Clinic at the expense of rural hospitals in regions like Appalachia and Midwest United States. Debates involve resource allocation, cost-effectiveness analyses from health economics researchers at institutions like Harvard Medical School and University of California, San Francisco, and concerns about variability in implementation noted by investigators from RAND Corporation and public health agencies. Other criticisms address potential conflicts between guideline-driven protocols and local practice environments, the pace of adoption of endovascular therapies highlighted by trials such as MR CLEAN and ESCAPE, and the equity of access to certified stroke centers across diverse populations including those served by Indian Health Service facilities.
Category:Medical organizations